Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$479,363,031
+$111,737,403 QoQ
Shares Held
399,659
-0.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
5.43%
of 13F equity value
Holder Rank
#153
of 4,621 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LGT Group Foundation holds $1,204,398,927 across 9 Drug Manufacturers - General names. LLY ranks #1 (39.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
399,659 | $479,363,031 | |
| 2 | AZN |
Astrazeneca PLC
|
1,980,315 | $375,507,326 | |
| 3 | JNJ |
Johnson & Johnson
|
527,334 | $133,927,012 | |
| 4 | ABBV |
AbbVie Inc.
|
441,958 | $111,214,309 | |
| 5 | PFE |
Pfizer Inc
|
2,367,455 | $57,008,312 | |
| 6 | MRK |
Merck & Co., Inc.
|
205,618 | $26,421,912 | |
| 7 | AMGN |
Amgen Inc
|
53,947 | $19,535,286 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
19,269 | $1,110,279 |
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,363,031 | 399,659 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $367,625,628 | 399,693 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $525,177,892 | 488,683 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $383,699,729 | 502,883 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $368,312,331 | 472,480 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $365,372,668 | 442,388 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $267,914,880 | 347,040 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $268,578,022 | 303,156 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $357,220,392 | 394,553 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $113,022,804 | 145,281 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $126,098,416 | 216,322 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $117,902,180 | 219,504 | Shares | Defined | 2023-11-06 | |
| 2023-06-30 | $103,936,283 | 221,622 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $74,762,875 | 217,701 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $84,191,122 | 230,131 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $60,444,783 | 186,933 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $68,395,016 | 210,946 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $46,715,535 | 163,130 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $33,169,601 | 120,084 | Shares | Defined | 2022-05-03 | |
| No filing history on record for this holder in this stock. | ||||||